
![]() |
|
|
|
||
|
Making Healthcare Work with Advancing Technologies
In 1964 Arthur Koestler wrote in the New Statesman, No scientist is admired for failing in the attempt to solve problems that lie beyond his competence. The most he can hope for is the kindly contempt earned by the Utopian politician. If politics is the art of the possible, research is surely the art of the soluble. Both are immensely practical-minded affairs. One of the beauties of medicine lies in the fact that it is both the art of the possible and the art of the soluble.
Making Medical Progress Accessible is an issue of convergence and cooperation between the two discrete but dramatically interdependent regulatory and clinical constituencies. Clarity and distinctness of vision must mark both the social and the biological scientist for the most efficient delivery of medical innovation.
It is by design that the chairman of this session comes from the world of information, for there is no more powerful voice than the press in the education of the end-user of medical innovation the patients. Whereas miracle, mystery, and authority may have sufficed for the Grand Inquisitor and for the physician and politician of yesteryear, today it is knowledge and understanding that counts above all else.
To believe that it is only in recent times that
the ethical implications of discovery were the subject of heated debate
would be to ignore history and the long line of innovators who have been
pilloried for their creativity. Usually, such assaults have been launched
by those with an interest in maintaining the status quo ante. Fortunately
for the good of mankind, reason has triumphed. This plenary session will
explore the true sources of innovation and expose the myths which have
come to dominate the discussion of those sources.
What is wrong with a civilized society spending 12 or 15 percent of its gross national product on healthcare, as long as it is spent honestly and efficiently? Is it really true that resources are not available to offer citizens the best of appropriate healthcare and health technology? Is the escalation in healthcare costs really due to the introduction of new technologies and innovative therapies, or rather to massive inefficiencies in the system? Should adequate healthcare be the very first priority of a society, rich or poor?
Seminar 2 will discuss new models of healthcare funding and payment. The Forum believes that while this is social engineering at its most difficult, it is neither grandiose or absurd to explore these questions.
Without adequate funding not only will innovation wither and die, but the fruits of innovation will remain inaccessible to the consumer and the payer. |
|
||
|
Session Chairman |
|||
|
|
|||
|
Keynote Speakers |
|||
|
|||
| Coffee Break, 20 Minutes | |||
|
|
|||
| Session Presenters | |||
|
|||
| Moderator | |||
|
|
|||
| Panel Members | |||
|
|
|||
| Moderator | |||
|
|
|||
| Panel Members | |||
|
|
![]() |
![]() |
![]() |
|
GMF | 2.0
|